| ORIGINAL ARTICLE |
|
| Year : 2020 | Volume
: 9
| Issue : 2 | Page : 127-130 |
|
|
Hodgkin's lymphoma of the childhood: Experience of single hemato-oncology center
Entisar Hadi Al-Shammary1, Mohammed Jassim Al-Lami2
1 Department of Pediatric Hematologist/Oncologist, Child's Central Teaching Hospital, Baghdad, Iraq
2 Department of Pediatrician, Child's Central Teaching Hospital, Baghdad, Iraq
Correspondence Address:
Dr. Entisar Hadi Al-Shammary
Child's Central Teaching Hospital, Baghdad
Iraq
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijh.ijh_30_20
|
|
|
BACKGROUND: Hodgkin's lymphoma (HL) is a malignant lymphoma that accounts for approximately 7% of childhood cancers. The incidence of HL in childhood varies by age; it is the most common childhood cancer in the age group of 15–19 years.
OBJECTIVE: The objective of the study is to determine the clinical presentation and outcome of HL among children under 15 years of age.
PATIENTS AND METHODS: A retrospective study carried out at the hemato-oncology department of child's central teaching hospital included 46 HL patients under 15 years of age who were diagnosed over 6 years from January 2010 to December 2015. Demographic characteristics, histopathological and clinical features, treatment modalities, response to treatment, and outcome were obtained from the records files of the patients.
RESULTS: Among a total of 46 children with HL, there were 33 (71.7%) males and 13 (28.3%) females; the male-to-female ratio was 2.1:1; the mean age of this study was 8.3 years. Lymphadenopathy was the most common sign, with cervical lymph node being the most common primary site of involvement. 47.8% of the atients present with Stage II, and the mixed cellularity histopathological subtypes were the common recognized subtype. Event-free survival (EFS) is 78.3%, and overall survival (OS) was 95.5%.
CONCLUSION: Two-year OS (95.5%) and EFS (78.3%) of the HL patients were accepted as compared to other studies.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
